Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

BACKGROUND: Sclerostin is a Wnt pathway antagonist regulating osteoblast activity and bone turnover. Here, we assessed the potential association of sclerostin with the development of coronary artery (CAC) and aortic valve calcifications (AVC) in haemodialysis (HD) patients. METHODS: We conducted a c...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Brandenburg, Vincent M, Kramann, Rafael, Koos, Ralf, Krüger, Thilo, Schurgers, Leon, Mühlenbruch, Georg, Hübner, Sinah, Gladziwa, Ulrich, Drechsler, Christiane, Ketteler, Markus
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2013
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3851854/
https://ncbi.nlm.nih.gov/pubmed/24112318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2369-14-219
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg